| Old | New | Differences | |
|---|---|---|---|
| 1 | 1 | 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB1258 Introduced 1/28/2025, by Sen. Graciela Guzmn SYNOPSIS AS INTRODUCED: 215 ILCS 200/52 new Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude. LRB104 08130 BAB 18176 b A BILL FOR 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB1258 Introduced 1/28/2025, by Sen. Graciela Guzmn SYNOPSIS AS INTRODUCED: 215 ILCS 200/52 new 215 ILCS 200/52 new Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude. LRB104 08130 BAB 18176 b LRB104 08130 BAB 18176 b A BILL FOR | |
| 2 | 2 | 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB1258 Introduced 1/28/2025, by Sen. Graciela Guzmn SYNOPSIS AS INTRODUCED: | |
| 3 | 3 | 215 ILCS 200/52 new 215 ILCS 200/52 new | |
| 4 | 4 | 215 ILCS 200/52 new | |
| 5 | 5 | Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude. | |
| 6 | 6 | LRB104 08130 BAB 18176 b LRB104 08130 BAB 18176 b | |
| 7 | 7 | LRB104 08130 BAB 18176 b | |
| 8 | 8 | A BILL FOR | |
| 9 | 9 | SB1258LRB104 08130 BAB 18176 b SB1258 LRB104 08130 BAB 18176 b | |
| 10 | 10 | SB1258 LRB104 08130 BAB 18176 b | |
| 11 | 11 | 1 AN ACT concerning regulation. | |
| 12 | 12 | 2 Be it enacted by the People of the State of Illinois, | |
| 13 | 13 | 3 represented in the General Assembly: | |
| 14 | 14 | 4 Section 5. The Prior Authorization Reform Act is amended | |
| 15 | 15 | 5 by adding Section 52 as follows: | |
| 16 | 16 | ||
| 17 | 17 | ||
| 18 | 18 | ||
| 19 | 19 | 104TH GENERAL ASSEMBLY State of Illinois 2025 and 2026 SB1258 Introduced 1/28/2025, by Sen. Graciela Guzmn SYNOPSIS AS INTRODUCED: | |
| 20 | 20 | 215 ILCS 200/52 new 215 ILCS 200/52 new | |
| 21 | 21 | 215 ILCS 200/52 new | |
| 22 | 22 | Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude. | |
| 23 | 23 | LRB104 08130 BAB 18176 b LRB104 08130 BAB 18176 b | |
| 24 | 24 | LRB104 08130 BAB 18176 b | |
| 25 | 25 | A BILL FOR | |
| 26 | 26 | ||
| 27 | 27 | ||
| 28 | 28 | ||
| 29 | 29 | ||
| 30 | 30 | ||
| 31 | 31 | 215 ILCS 200/52 new | |
| 32 | 32 | ||
| 33 | 33 | ||
| 34 | 34 | ||
| 35 | 35 | LRB104 08130 BAB 18176 b | |
| 36 | 36 | ||
| 37 | 37 | ||
| 38 | 38 | ||
| 39 | 39 | ||
| 40 | 40 | ||
| 41 | 41 | ||
| 42 | 42 | ||
| 43 | 43 | ||
| 44 | 44 | ||
| 45 | 45 | SB1258 LRB104 08130 BAB 18176 b |